Dr. Justin Sanchez is serving as the Director (SES) of the Biological Technologies Office (BTO) at DARPA. The mission of BTO is to develop breakthrough technologies for national security. Current areas of science and technology development include neurotechnology, tools for synthetic biology, and outpacing infectious diseases. He joined DARPA as a program manager in 2013 to explore neurotechnology, brain science and systems neurobiology. Before joining DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders and neuropsychiatric illness. Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system. He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design, and authored two books on the design of brain-machine interfaces. He has served as a reviewer for the NIH, DoD, and Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology. He has mentored over 20 PhD students, Masters Students, and Postdoctoral Associates in the field of neuroprosthetics. Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida.